Compounding/Track And Trace Bill Another Victim Of Shutdown
This article was originally published in The Pink Sheet Daily
Executive Summary
The stripped down version will generate considerably less user fee revenue for FDA, but so far it has met the same fate in the Senate as other recent legislation coming from the House.
You may also be interested in...
FDA’s Shutdown Plan: Some User Fee Services Would Continue; Routine Inspections Would Not
The agency would retain 8,180 staff members, about 55% of its total, mostly because they could be “paid from carryover funding.”
Compounding Bill In Senate Gets Bipartisan Push For Floor Vote
HELP Committee leaders Harkin and Alexander write letter arguing that FDA’s warnings of more problems from tainted compounded medications have come true and that their legislation should gain a vote next month.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.